not losing weight on semaglutide compound Tirzepatide? Dietitian Explains Why 5 Reasons You Aren't Losing
Description
Medicare Part D claims for Ozempic, Rybelsus, Trulicity, and Mounjaro increased from 1.4 million in 2018 to 8.7 million in 2022 (Figure 1)
However, prolonged exposure above 86F can begin degrading the peptide

Notes : * GRLS The State Register of maximal manufacturing prices

Metabolism A metabolism study in humans indicates that insulin glargine is partly metabolized at the carboxyl terminus of the B chain in the subcutaneous depot to form two active metabolites with in vitro activity similar to that of human insulin, M1 (21A-Gly-insulin) and M2 (21A-Gly-des- 30B-Thr-insulin)

The FDA tracks these side effects and looks at patterns, severity, and frequency to help them determine if a new boxed warning needs to be added for a drug

Mol Endocrinol 11:10941102
